Found 52 matching trials
AZD2171 in Treating Patients With Refractory Metastatic Kidney Cancer PHASE2 This phase II trial is studying how well AZD2171 works in treating patients...
Show More Location
University of Chicago
Learn More & Join Trial
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone PHASE2 This phase II trial studies the effects of the combination of olaparib and ...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers PHASE2 This phase II trial is studying how well giving cediranib maleate together ...
Show More Location
Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
Learn More & Join Trial
Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer PHASE2 This phase II trial studies how well olaparib and cediranib maleate work in...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Learn More & Join Trial
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PHASE3 This phase III trial studies olaparib or cediranib maleate and olaparib to ...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer PHASE1 This phase I trial is studying the side effects and best dose of cediranib ...
Show More Location
Massachusetts General Hospital Cancer Center
Learn More & Join Trial
Cediranib Maleate in Treating Patients With Recurrent or Metastatic Kidney Cancer That Cannot Be Removed By Surgery PHASE2 This phase II trial studies how well cediranib maleate works in treating pa...
Show More Location
Cross Cancer Institute
Learn More & Join Trial
AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma PHASE2 This phase II trial is studying how well AZD2171 works in treating patients...
Show More Location
Princess Margaret Hospital Phase 2 Consortium
Learn More & Join Trial
AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme PHASE2 This phase II trial is studying how well AZD2171 works in treating patients...
Show More Location
Massachusetts General Hospital Cancer Center
Learn More & Join Trial
Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome PHASE2 This phase II trial is studying how well cediranib maleate works in treatin...
Show More Location
Howard University Hospital
Learn More & Join Trial